NextGen Healthcare, Inc. Reports Fiscal 2019 Second Quarter Results

Go back to NextGen Healthcare, Inc. Reports Fiscal 2019 Second Quarter Results

Morgan Stanley Upgrades NextGen Healthcare Inc (NXGN) to Equalweight

November 1, 2018 1:54 PM EDT

Morgan Stanley analyst Ricky Goldwasser upgraded NextGen Healthcare Inc (NASDAQ: NXGN) from Underweight to Equalweight with a price target of $16.00.

For an analyst ratings summary and ratings history on NextGen Healthcare Inc... More

NextGen Healthcare Inc (NXGN) PT Lowered to $15 at RBC Capital

October 31, 2018 7:52 AM EDT

RBC Capital analyst George Hill lowered the price target on NextGen Healthcare Inc (NASDAQ: NXGN) to $15.00 (from $17.00) while maintaining a Underperform rating.

... More

Nexgen Biofuels (NXGN) Tops Q2 EPS by 5c

October 30, 2018 4:52 PM EDT

Nexgen Biofuels (NASDAQ: NXGN) reported Q2 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $130.3 million versus the consensus estimate of $134.55 million.

GUIDANCE:

Nexgen Biofuels sees FY2019 EPS of $0.70-$0.74, versus the consensus of... More